Comparisons between the National Comprehensive Cancer Network (NCCN) non-small-cell lung cancer (NSCLC) Clinical Practice Guidelines (Chinese version), the NCCN original edition, and the European Society for Medical Oncology NSCLC Guidelines in 2009

Yan Xu; Hongyu Liu; Jun Chen; Qinghua Zhou

doi:10.1111/j.1759-7714.2010.00016.x

Comparisons between the National Comprehensive Cancer Network (NCCN) non-small-cell lung cancer (NSCLC) Clinical Practice Guidelines (Chinese version), the NCCN original edition, and the European Society for Medical Oncology NSCLC Guidelines in 2009

Thorac Cancer. 2010 Jul;1(2):83-86. doi: 10.1111/j.1759-7714.2010.00016.x. Epub 2010 May 19.

Authors

Yan Xu¹, Hongyu Liu¹, Jun Chen¹, Qinghua Zhou¹

Affiliation

¹ Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin, China.

PMID: 27755782
DOI: 10.1111/j.1759-7714.2010.00016.x

Abstract

The National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines for various malignant tumors have been widely recognized and followed by global oncologists, in order to promote the standardization of cancer treatment and to provide the best treatment recommendations for cancer patients. However, there are still some differences in different countries and areas based on the specific conditions. In this paper, we compared the differences between NCCN non-small-cell lung cancer Clinical Practice Guidelines (Chinese version), the NCCN original edition, and European Society for Medical Oncology non-small-cell lung cancer guidelines.

Keywords: Chemotherapy; non-small-cell lung cancer (NSCLC); radiotherapy; the National Comprehensive Cancer Network (NCCN).